Epieduca is an intervention program for people affected by epilepsy in the educational environment through technology

The Epieduca initiative, promoted by the entity Apoodravet, MJN Neuroserveis as a technological promoter and the financial support of the QUAES Foundation, will allow the integration of all those young people who, due to drug-resistant epilepsy, are at high risk of suffering seizures in the school environment. This risk situation directly affects the autonomy of these young people for many routine tasks, which affects their levels of self-esteem and can cause depression and/or anxiety affecting their social relationships and ultimately be isolated from other partners.

Epieduca enables an inclusive education

Using current information and communication technologies such as smartphones and wearable sensors, teachers will be equipped with a mobile application that will indicate through a traffic light, the risk level of the student to suffer an epileptic seizure and for each risk situation some advice.

  • Green traffic light: the child can do all school activities with a very low risk of crisis.
  • Yellow traffic light: in a period of risk, we will change activity, distraction, and relaxation.
  • Red traffic light: Initiation of the safety protocol with the objective that the student waits for the possible crisis in a safe environment supervised by caregivers or teachers assigned. Once the traffic light turns green, the student can return to normal activities.

The technology that makes the Epieduca project possible

Through the non-invasive atrial sensor SERAS_Epilepsy that records the brain activity of at-risk students and a mobile app with Artificial Intelligence (AI) algorithms that learn the biometric patterns of the user to detect and alert of an epileptic seizure. The application will send alerts to relatives/caregivers/teachers and 112 as well as the user’s GPS location. The app will also include customizable serious games.

The benefits of the Epieduca program

  • Align educational dynamics with the temporal pattern of brain excitation in people affected by epilepsy.
  • Elimination of uncertainty of the student’s environment of not knowing when a crisis will occur.
  • Elimination of the risk of accidents due to the crisis.
  • Increased security and autonomy of the affected person.
  • Knowledge by peers that epilepsy is a perfectly manageable disease.

The Epieduca programme is currently under development.

MJN Neuroserveis is born to improve the quality life of people suffering from epilepsy and their environment, for this reason, they do not only develop cutting-edge technology that allows greater autonomy and safety to the affected but also involving itself in the most social aspects to destigmatize the disease and facilitate the inclusion of this group.

With the collaboration of:

Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.